Does it excite you to work at the frontier of peptide and mini-protein drug discovery, and do you have hands-on experience with mRNA display technology? If this sounds like you, and you are ready to help build a new discovery platform from the ground up, then you could be our new colleague.
Your new position
As a Scientist or Senior Scientist in mRNA Display, you will play a central scientific role in our new Molecular Platform Development organization, driving peptide and mini-protein discovery through mRNA display technology. You will help build and operate a modern, high-throughput display platform at the inception of our new Cambridge, MA research center. This role suits a scientist with strong technical expertise across the full mRNA display workflow, scientific curiosity, and a desire to grow in scope and responsibility.
We offer exciting responsibilities:
- Execute the full peptide and mini-protein mRNA display workflow, from library design and in vitro transcription/translation through puromycin-based fusion, selection, and enrichment
- Apply expertise in non-canonical amino acid incorporation to expand chemical diversity within display libraries
- Apply chemical modification strategies—including macrocyclization/stapling, lipidation, and bioconjugation—to improve potency, stability, and pharmacokinetic properties
- Build and maintain custom cell-free display systems in-house, including establishing mRNA display platforms from scratch
- Generate and analyze structure-activity relationship (SAR) data to support optimization of selected hits, contributing to lead and backup candidate selection
- Collaborate with computational modeling, design, and data science colleagues to support efficient DMTA cycles
Your profile
You bring strong technical expertise across the peptide and mini-protein mRNA display workflow, along with scientific curiosity and sound judgment. You thrive in a collaborative, multidisciplinary environment and are motivated to help shape a new platform and research center from an early stage. You communicate scientific data and concepts clearly and work effectively across cross-functional project teams.
- PhD in Chemical Biology, Biochemistry, Organic Chemistry, or a related field preferred (postdoctoral training preferred); candidates with a BS/MS and significantly more relevant industry experience will also be considered
- 2+ years of relevant post-degree experience in mRNA display or related in vitro display technologies (Scientist); 4+ years (Senior Scientist)
- Experience building custom cell-free display systems from scratch strongly preferred; experience with other in vitro display technologies (e.g., ribosome display) and cell-free protein/peptide expression systems (e.g., IVTT, CFS) is a plus
- Experience incorporating non-canonical amino acids via reprogrammed translation systems (e.g., flexizyme-based methods) or related approaches
- Experience applying next-generation sequencing (NGS) to analyze library diversity and selection enrichment; familiarity with associated bioinformatics is a plus
- Familiarity with analytical characterization of peptides (e.g., LC-MS-based methods) and peptide developability considerations (stability, solubility, manufacturability)
Your new team
You will join Molecular Platform Development, a new organization created to strengthen and advance diverse drug modality capabilities in metabolic disease, based at our new Cambridge, MA research center. The site is a highly collaborative, multidisciplinary discovery hub integrating computational research, chemistry, and biology, and is deeply connected to the Greater Boston life sciences ecosystem.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Salary Range: $125,000 - $170,000
Interested in bonding with us? The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Cambridge, Massachusetts. Learn more at www.zealandpharma.com.
Skills Required
- 2+ years post-degree experience in mRNA display or related in vitro display technologies (Scientist) or 4+ years for Senior Scientist
- Hands-on experience executing full mRNA display workflow including library design, in vitro transcription/translation, puromycin-based fusion, selection, and enrichment
- Experience incorporating non-canonical amino acids via reprogrammed translation systems (e.g., flexizyme-based methods)
- Experience building and maintaining custom cell-free display systems (establishing mRNA display platforms from scratch)
- Experience applying next-generation sequencing to analyze library diversity and selection enrichment
- Familiarity with associated bioinformatics analysis of NGS selection data
- Familiarity with analytical characterization of peptides (e.g., LC-MS) and peptide developability considerations (stability, solubility, manufacturability)
- Experience applying chemical modification strategies (macrocyclization/stapling, lipidation, bioconjugation) to improve peptide properties
- Strong collaboration, communication, scientific curiosity, and ability to work across multidisciplinary teams
- PhD in Chemical Biology, Biochemistry, Organic Chemistry, or related field preferred (postdoctoral training preferred); BS/MS considered with significant industry experience
What We Do
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn







